These data provide the theoretical background for probing more deeply into the role of HIF-1a in the BM microenvironment in MDS and provide further justification for the use of HIF-1 inhibitors in this disorder, an issue that is currently under investigation (79). This evidence concerns the gene HIF1A and myelodysplastic syndrome.